Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

In January 2025, Lizzo celebrated a milestone: she hit her personal "weight release goal," revealing she had dropped her body ...

Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese ...

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Taking to platforms including Reddit and Telegram for guidance, buyers import small quantities, often described as research ...

Drug services provider Medtide (3880.HK) is looking to raise HK$514 million (410 million yuan or $65.48 million) in a listing ...

Among a plethora of weight-management plans and dietary charts (namely, keto, dash, sirtfood, paleo or crash diet), climbing the popularity charts, incretin hormone therapy is currently grabbing ...

The FDA now requires ADHD extended-release drug labels to warn of weight loss risks in children under 6, urging monitoring ...

A caloric deficit is when you burn more calories than you eat in a day. As Maitland mentioned, it's usually recommended to start a deficit by cutting back 500 calories a day from your diet. It's ...

Lizzo appeared to admit on the Just Trish podcast on Thursday (June 19) that she'd tried a weight loss drug, despite previously denying rumours. The 'Rumours' singer was asked by Trisha Paytas if ...